Blue Cross NC prior authorization criteria
Documentation packets and P2P preparation by drug—for prescribers and PA staff. Verify the current member-specific payer criteria and timing before submission.
Blue Cross NC reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. The applicable product, plan terms, request type, urgency, and governing law determine the decision and appeal clocks. Confirm both in the current member-specific source and denial notice. Criteria by drug appear below.
Prior authorization criteria by drug
Each page covers Blue Cross NC's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Blue Cross NC →
- Aflibercept at Blue Cross NC →
- Apixaban at Blue Cross NC →
- Atezolizumab at Blue Cross NC →
- Atogepant at Blue Cross NC →
- Benralizumab at Blue Cross NC →
- Bevacizumab at Blue Cross NC →
- Bictegravir at Blue Cross NC →
- Buprenorphine at Blue Cross NC →
- Dapagliflozin at Blue Cross NC →
- Dulaglutide at Blue Cross NC →
- Dupilumab at Blue Cross NC →
- Eculizumab at Blue Cross NC →
- Elexacaftor Tezacaftor Ivacaftor at Blue Cross NC →
- Empagliflozin at Blue Cross NC →
- Erenumab at Blue Cross NC →
- Evolocumab at Blue Cross NC →
- Faricimab at Blue Cross NC →
- Fingolimod at Blue Cross NC →
- Fremanezumab at Blue Cross NC →
- Galcanezumab at Blue Cross NC →
- Glecaprevir Pibrentasvir at Blue Cross NC →
- Guselkumab at Blue Cross NC →
- Ibrutinib at Blue Cross NC →
- Imatinib at Blue Cross NC →
- Inclisiran at Blue Cross NC →
- Infliximab at Blue Cross NC →
- Ixekizumab at Blue Cross NC →
- Lenalidomide at Blue Cross NC →
- Liraglutide at Blue Cross NC →
- Lisdexamfetamine at Blue Cross NC →
- Mepolizumab at Blue Cross NC →
- Methylphenidate at Blue Cross NC →
- Naltrexone at Blue Cross NC →
- Natalizumab at Blue Cross NC →
- Nintedanib at Blue Cross NC →
- Nivolumab at Blue Cross NC →
- Nusinersen at Blue Cross NC →
- Ocrelizumab at Blue Cross NC →
- Ofatumumab at Blue Cross NC →
- Omalizumab at Blue Cross NC →
- Ozanimod at Blue Cross NC →
- Palbociclib at Blue Cross NC →
- Pembrolizumab at Blue Cross NC →
- Pirfenidone at Blue Cross NC →
- Ribociclib at Blue Cross NC →
- Rimegepant at Blue Cross NC →
- Risankizumab at Blue Cross NC →
- Rituximab at Blue Cross NC →
- Rivaroxaban at Blue Cross NC →
- Sacubitril Valsartan at Blue Cross NC →
- Secukinumab at Blue Cross NC →
- Semaglutide at Blue Cross NC →
- Sofosbuvir at Blue Cross NC →
- Tafamidis at Blue Cross NC →
- Tenofovir Alafenamide at Blue Cross NC →
- Tezepelumab at Blue Cross NC →
- Tirzepatide at Blue Cross NC →
- Tofacitinib at Blue Cross NC →
- Trastuzumab at Blue Cross NC →
- Upadacitinib at Blue Cross NC →
- Ustekinumab at Blue Cross NC →
Generate a Blue Cross NC PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Blue Cross NC's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com